The clinically reported adverse effects of anti-VEGF antibody, bevacizumab, are hemorrhage, arterial thromboembolic events, hypertension, proteinuria, anorexia, stomatitis, diarrhea and etc [48]. Here, VEGFA is linked to hypertensive disorder.